Standardised reports with a template format are superior to free text reports: the case for rectal cancer reporting in clinical practice.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 11 10 2018
accepted: 21 01 2019
revised: 03 01 2019
pubmed: 24 2 2019
medline: 18 12 2019
entrez: 24 2 2019
Statut: ppublish

Résumé

Rectal cancer staging with magnetic resonance imaging (MRI) allows accurate assessment and preoperative staging of rectal cancers. Therefore, complete MRI reports are vital to treatment planning. Significant variability may exist in their content and completeness. Template-style reporting can improve reporting standards, but its use is not widespread. Given the implications for treatment, we have evaluated current clinical practice amongst specialist gastrointestinal (GI) radiologists to measure the quality of rectal cancer staging MRI reports. Sixteen United Kingdom (UK) colorectal cancer multi-disciplinary teams (CRC-MDTs) serving a population over 5 million were invited to submit up to 10 consecutive rectal cancer primary staging MRI reports from January 2016 for each radiologist participating in the CRC-MDT. Reports were compared to a reference standard based on recognised staging and prognostic factors influencing case management RESULTS: Four hundred ten primary staging reports were submitted from 41 of 42 (97.6%) eligible radiologists. Three hundred sixty reports met the inclusion criteria, of these, 81 (22.5%) used a template. Template report usage significantly increased recording of key data points versus non-template reports for extra-mural venous invasion (EMVI) status (98.8% v 51.6%, p < 0.01) and circumferential resection margin (CRM) status (96.3% v 65.9%, p < 0.01). Local tumour stage (97.5% v 93.5%, NS) and nodal status (98.8% v 96.1%, NS) were reported and with similar frequency. Rectal cancer primary staging reports do not meet published standards. Template-style reports have significant increases in the inclusion of key tumour descriptors. This study provides further support for their use to improve reporting standards and outcomes in rectal cancer. • MRI primary staging of rectal cancer requires detailed tumour descriptions as these alter the neoadjuvant and surgical treatments. • Currently, rectal cancer MRI reports in clinical practice do not provide sufficient detail on these tumour descriptors. • The use of template-style reports for primary staging of rectal cancer significantly improves report quality compared to free-text reports.

Identifiants

pubmed: 30796574
doi: 10.1007/s00330-019-06028-8
pii: 10.1007/s00330-019-06028-8
pmc: PMC6682848
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

5121-5128

Subventions

Organisme : Medical Research Council
ID : MR/L01629X/1
Pays : United Kingdom
Organisme : Yorkshire Cancer Research
ID : L394
Pays : United Kingdom

Références

Int J Colorectal Dis. 2001 Sep;16(5):298-304
pubmed: 11686527
Am J Surg Pathol. 2002 Mar;26(3):350-7
pubmed: 11859207
Ann Surg. 2002 Apr;235(4):449-57
pubmed: 11923599
Br J Surg. 2003 Mar;90(3):355-64
pubmed: 12594673
Radiology. 2003 May;227(2):371-7
pubmed: 12732695
BMJ. 2006 Oct 14;333(7572):779
pubmed: 16984925
Radiology. 2008 Dec;249(3):739-47
pubmed: 19011178
J Gastrointest Surg. 2011 Mar;15(3):444-50
pubmed: 21140237
Radiology. 2011 Jul;260(1):174-81
pubmed: 21518775
Clin Radiol. 2011 Nov;66(11):1015-22
pubmed: 21788016
Br J Surg. 2012 Jul;99(7):918-28
pubmed: 22362002
Arch Pathol Lab Med. 2012 Jun;136(6):652-6
pubmed: 22646273
Ann Surg Oncol. 2013 Apr;20(4):1148-55
pubmed: 23143592
Radiology. 2013 Oct;269(1):101-12
pubmed: 23801777
J Clin Pathol. 2014 Jun;67(6):499-505
pubmed: 24567415
Dis Colon Rectum. 2014 Jun;57(6):790-9
pubmed: 24807605
AJR Am J Roentgenol. 2014 Jun;202(6):1238-44
pubmed: 24848820
Radiother Oncol. 2014 Nov;113(2):158-65
pubmed: 25483833
Cochrane Database Syst Rev. 2015 Apr 29;(4):CD005470
pubmed: 25923419
AJR Am J Roentgenol. 2015 Sep;205(3):584-8
pubmed: 26295645
Virchows Arch. 2016 Jun;468(6):639-49
pubmed: 27097810
Pathology. 2016 Jun;48(4):349-52
pubmed: 27114373
Invest Radiol. 2017 Apr;52(4):232-239
pubmed: 27861230
Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40
pubmed: 28881920
Eur J Surg Oncol. 2017 Nov;43(11):2093-2104
pubmed: 28947340
Acad Radiol. 2018 Jan;25(1):66-73
pubmed: 29030284
Eur Radiol. 2018 Apr;28(4):1465-1475
pubmed: 29043428
Insights Imaging. 2018 Feb;9(1):1-7
pubmed: 29460129
Abdom Radiol (NY). 2018 Nov;43(11):2893-2902
pubmed: 29785540

Auteurs

P J Brown (PJ)

Department of Clinical Radiology, Lincoln Wing, Leeds Teaching Hospitals NHS Trust, St James' University Hospital, Beckett Street, Leeds, LS9 7TF, UK. peter.brown30@nhs.net.

H Rossington (H)

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, St James's Institute of Oncology, St James's University Hospital, University of Leeds, Leeds, LS9 7TF, UK.

J Taylor (J)

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, St James's Institute of Oncology, St James's University Hospital, University of Leeds, Leeds, LS9 7TF, UK.

D M J Lambregts (DMJ)

Department of Radiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE, Amsterdam, Netherlands.

E Morris (E)

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, St James's Institute of Oncology, St James's University Hospital, University of Leeds, Leeds, LS9 7TF, UK.

N P West (NP)

Section of Pathology and Tumour Biology, Leeds Institute of Cancer & Pathology, St James's University Hospital, University of Leeds, Leeds, LS9 7TF, UK.

P Quirke (P)

Section of Pathology and Tumour Biology, Leeds Institute of Cancer & Pathology, St James's University Hospital, University of Leeds, Leeds, LS9 7TF, UK.

D Tolan (D)

Department of Clinical Radiology, Lincoln Wing, Leeds Teaching Hospitals NHS Trust, St James' University Hospital, Beckett Street, Leeds, LS9 7TF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH